BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200702T110000
DTEND;TZID=Europe/London:20200702T120000
DTSTAMP:20260422T074448
CREATED:20200619T074904Z
LAST-MODIFIED:20200619T074904Z
UID:18229-1593687600-1593691200@staging.medilinkmidlands.com
SUMMARY:Webinar: Business Re-organisation to Protect your assets and to manage staffing issues
DESCRIPTION:Join Shakespeare Martineau Partners\, Sean Moran and Rhys Wyborn\, for a discussion of important considerations around business re-organisations and protecting assets\, including staffing issues that may arise. \nSean will provide an overview of directors’ duties and guidance on preserving value in your business.  Rhys will then conclude the session by looking at key issues arising from business restructures and key redundancy considerations employers should be aware of. \nThis webinar will therefore cover:\n-Important director duties \n-Business restructuring and ways to preserve value in your business \n-Redundancy procedures and consultation \n-Redundancy v. furlough \nThis webinar is open to Life Science businesses who are seeking to learn about preserving value in your business and carrying our redundancy processes correctly and who wish to ask questions directly to the experts. \nDURATION: 1 hour\nThis free to attend webinar will be held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund. Click here to be redirected to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles \nSean Moran\, Partner – Shakespeare Martineau \nSean is a partner at SHMA acting for insolvency practitioners\, companies and individuals on all aspects of insolvency\, restructuring and turnaround. His practice covers both contentious and non-contentious assignments\, providing advice to directors on their duties and responsibilities as well as undertaking transactional work and insolvency-related litigation. \n  \n  \n \n  \nRhys Wyborn\, Partner\, Shakespeare Martineau\nRhys is an employment law specialist helping employers manage their staff and HR issues from recruitment through to termination of the employment relationship\, with everything in between! Specialisms include: – handling disciplinary and grievance issues; defending unfair dismissal and discrimination claims; redundancy and business reorganisations; TUPE transfers and corporate support; drafting bespoke employment contracts and HR policies. He is also regularly instructed to advise on severance agreements for senior executives and other employees\, including the drafting of terms and negotiating matters to a conclusion. Rhys also provides training on HR issues via seminars and forums and bespoke training events for clients including Mock Tribunals and managing investigations.
URL:https://staging.medilinkmidlands.com/event/webinar-business-re-organisation-to-protect-your-assets-and-to-manage-staffing-issues/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Sean_Moran2-scaled.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200708T103000
DTEND;TZID=Europe/London:20200708T113000
DTSTAMP:20260422T074448
CREATED:20200518T115538Z
LAST-MODIFIED:20200518T115538Z
UID:18226-1594204200-1594207800@staging.medilinkmidlands.com
SUMMARY:East Midlands Academic Health Science Network Virtual Coffee Break
DESCRIPTION:A chance to meet other businesses\, share ideas and hear what’s happening from the East Midlands Academic Health Science Network Team. \nJoin EMAHSN for a virtual coffee break on Wednesday 8 July at 10.30am. \nNetworking opportunities are a key part of Medilink EM events and whilst the current COVID-19 crisis won’t allow face to face events\, we have introduced this online opportunity to enable the life sciences community to still connect with one another. In this informal gathering\, hosted by Nick Brown\, Commercial Manager at EMAHSN\, you will have the opportunity to share your current challenges and experiences and find out how the EMAHSN can help. \nThe theme for this coffee break is regulatory/CE marking & making sure you meet the standards and we will be joined by Dr Sarah Bolton\, Business Manager from CHEATA (The Centre for Healthcare Equipment & Technology Adoption). CHEATA offer a unique contract-based support service to clinical\, academic and commercial med-tech developers to gather evidence for NHS adoption and to help their clients develop devices that are truly NHS-ready. \nGrab a coffee\, a biscuit and join us. \nJoining details will provided to delegates by a member of the Medilink EM events team once the online registration form has been completed. \nIf you have any topics that you’d like to discuss in future AHSN coffee breaks\, please feel free to email any suggestions to us by clicking here. \n\nChair and guest details: \n \n  \nNick Brown\, Commercial Manager\, EMAHSN \n  \n  \n  \n Dr Sarah Bolton\, Business Manager\, CHEATA
URL:https://staging.medilinkmidlands.com/event/east-midlands-academic-health-science-network-virtual-coffee-break-2-2-2/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/gif:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Sarah-Boltonweb-1.gif
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200709T110000
DTEND;TZID=Europe/London:20200709T120000
DTSTAMP:20260422T074448
CREATED:20200515T081236Z
LAST-MODIFIED:20200515T081236Z
UID:18171-1594292400-1594296000@staging.medilinkmidlands.com
SUMMARY:Webinar: Opportunities in Medtech Innovation: Long-term neurological conditions
DESCRIPTION:People living with long-term neurological conditions (e.g. MND\, MS\, Parkinson’s Disease) are reported to have the lowest health-related quality of life of any long-term condition\, with the numbers of people affected continuing to rise. \nAs society and healthcare systems respond and adapt to the impact of the COVID-19 pandemic\, this webinar is an opportunity for businesses to: \n• understand the key challenges affecting patients & the health and care system\,\n• learn about the market for technology solutions within new models of care & self-management\, &\n• connect with collaborative networks to catalyse & advance product innovation. \nOur speakers from NIHR Devices for Dignity will give you the opportunity to ask any questions you may have during the webinar. \nThis webinar is open to Life Science businesses who are seeking to learn about the opportunities in medtech innovation and wish to ask questions directly to the experts. \nThis free to attend meeting will be held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund. Click here to be redirected to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n \nProfessor Christopher McDermott\, Professor of Translational Neurology at Sheffield Institute for Translational Neuroscience (SiTRAN) at the University of Sheffield and Consultat Neurologist at Sheffield Teaching Hospitals NHS Foundation Trust\, – leading research programmes developing supportive interventions to improve care of individuals living with neurological conditions \n  \n  \n  \n \nPhilippa Hedley-Takhar\, Business Development Manager for NIHR Devices for Dignity Medtech Cooperative\, a national collaborative network catalysing technology development for chronic health conditions associated with loss of dignity and independence. \n 
URL:https://staging.medilinkmidlands.com/event/webinar-opportunities-in-medtech-innovation-long-term-neurological-conditions/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Chris-McDermott.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200714T140000
DTEND;TZID=Europe/London:20200714T150000
DTSTAMP:20260422T074448
CREATED:20200611T124941Z
LAST-MODIFIED:20200611T124941Z
UID:18209-1594735200-1594738800@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Food Supplements Special Interest Group (SIG) - a focus on Vitamin D
DESCRIPTION:Join us online for our next Food Supplements Special Interest Group (SIG) to hear about how Vitamin D continues to be a nutrient that dominates the media headlines\, whether due to nutritional deficiency\, national guidelines to supplement or as a panacea for good health.\nWe invite you to hear some of the facts around Vitamin D\, with our speaker Steve Simbler\, a pharmacist who has more than 20 years’ experience in medicines management in sport. Steve is the Head of the Sports Division at Synergy Biologics\, who have Pro D3 within their portfolio. Steve has a professional view to share about Vitamin D and its role in supplementation in all our lives. \n– Does vitamin D fall into the category of what we classically know as a vitamin?\n– What is the best form of vitamin D for us\, and how much and how often do we need it?\n– What is the best/safest way for us to obtain vitamin D?\n– What does it actually mean when we are vitamin D deficient/insufficient/sufficient\, and what can go wrong if our levels are low?\n– Is the attitude to vitamin D the same globally\, and in particular what are the UK recommendations?\n– What are the ramifications of recent government directives reducing NHS access to maintenance doses of vitamins?\n– Why are professional athletes often taking higher dosages of vitamin D? \nAs well as the opportunity to hear some facts about Vitamin D you can take part in a question and answer session. \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles \n\nSteve Simbler MRPharm.S\, Head of Sports Division\, Synergy Biologics \nSteve has been working as a pharmacist in elite sport for over 20 years\, initially in a supply capacity\, and for the past 10 years in providing medicines management consultancy and software to teams in the Premier League and English Football League as well as national governing bodies for football\, rugby\, athletics\, tennis\, cricket\, rowing\, and cycling amongst others.\nHe was one of the lead pharmacists for the London 2012 Olympics and Paralympics\, then again for the London 2017 Athletics and Para-Athletics World Championships.\nAs well as giving talks about vitamin D\, he lectures on various topics pertaining to drugs in sport and the use of analgesics and anti-inflammatories in sport.\nIn 2006\, sport doctors approached Steve to advise on obtaining a reliable source of vitamin D that could pass tests for WADA-prohibited substances\, this prompted an association with Synergy Biologics\, makers of Pro D3\, and this relationship is ongoing\, and stimulated an interest in vitamin D on which he keeps abreast of research\, and reads extensively.\nSince 2016 Steve has been a pharmacist panel member for the General Pharmaceutical Council’s Fitness to Practise Committee\, and has recently started as an NHS Test and Trace clinical contact tracer on a part time basis. \n\nJanet Worrell\, Head of Regulatory\, JensonR+\nJanet is an experienced regulatory affairs professional\, having supported a diverse portfolio of products\, for a number of companies across the East Midlands. Janet’s experience covers early concept development\, food supplements\, over the counter (OTC) medicines\, inhaled therapies and clinical trial applications. Janet enjoys collaborating with companies to develop their regulatory strategy to deliver commercial success. Janet is an independent board member of the East Midlands Academic Health Science Network supporting innovation within NHS.
URL:https://staging.medilinkmidlands.com/event/webinar-food-supplements-special-interest-group-sig/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Steve-Simbler-Image-small.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200715T110000
DTEND;TZID=Europe/London:20200715T120000
DTSTAMP:20260422T074448
CREATED:20200615T125511Z
LAST-MODIFIED:20200615T125511Z
UID:18216-1594810800-1594814400@staging.medilinkmidlands.com
SUMMARY:WEBINAR: How to pitch to Investors as a Life Science Company
DESCRIPTION:This webinar introduces life science and healthcare SMES and innovators to some of the key factors to consider when approaching private investors for funding. \nAlongside speakers from BioCity and the East Midlands Academic Health Science Network\, the webinar will cover: \n-What investors are looking for \n-Why startups fail \n-Finding product-market fit \n-Telling the story \nPlus there will be the opportunity to ask questions directly to the presenters. \nDURATION: 1 hour \nSpeakers: \n \nAisha Ajij\, Project Support and Industry Liaison Officer\, East Midlands Academic Health Science Network \nAisha has worked at the East Midlands Academic Health Science Network (EMAHSN) since 2014. She has experience in working with innovators from industry\, NHS and academia. She works with companies helping them to navigate the NHS marketplace and provides advice\, support and signposting to help them to develop their offer. Aisha organises and supports a number of consultation sessions on behalf of the EMAHSN. She is passionate about making innovations more accessible for patients and clinicians. \n  \n  \n  \n Dr Ayokunmi Ajetunmobi\, Venture Development Manager\, BioCity Group \nHelps entrepreneurs build breakthrough life science and healthcare ventures. Currently leading venture development activities at BioCity Group. Provide scientific\, entrepreneurial\, and business development expertise for the creation of venture-backed companies solving global challenges in health and the environment. Previous experience in a venture-backed biotech startup enabling therapeutic applications of genome editing. \n  \n  \n  \n  \n 
URL:https://staging.medilinkmidlands.com/event/webinar-how-to-pitch-to-investors-as-a-life-science-company/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Ayokunmi-Ajetunmobi.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200716T100000
DTEND;TZID=Europe/London:20200716T113000
DTSTAMP:20260422T074448
CREATED:20200325T135017Z
LAST-MODIFIED:20200325T135017Z
UID:18094-1594893600-1594899000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Medical Technologies & Systems Special Interest Group (SIG)
DESCRIPTION:The next Medical Technologies & Systems Special Interest Group (SIG) will take place online\, join us as we discuss Digital Health: Current Applications and Future Trends for Mental Healthcare. \nTalks at this webinar will include: \n– The impact of COVID-19 on Mental Health \n– Evaluating new technologies for mental health \n– Deriving Clinical Outcome Measures from Expression and Speech for use as Clinical Trial Endpoints: Results of a Proof of Concept Study \nDURATION: 1.5 hours \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles:  \n\nProfessor Philip Breedon\, Professor of Smart Technologies\, Nottingham Trent University \nAs well as his role at Nottingham Trent University\, Philip is also a Chartered Engineer and a Chartered IT professional. He is a member of the Department of Health’s National Institute for Health Research invention for innovation funding panel and holds a number of journal editorial positions. His research interests and latest projects centre on new and emerging technologies and materials. This includes wearable technologies\, 3D printing of pathological models\, additive and subtractive manufacturing for medical applications\, surgical robotics\, cardiovascular devices\, augmented /virtual/immersive technologies and environments\, the surgical pathway and investigative research related to the utilisation of ‘smart materials’ for medical applications. Through promoting his work and research activities he now works with a number of surgeons and clinicians across Europe. \n \nDr Louise Thomson\, Assistant Professor in Occupational Psychology and Practitioner Psychologist\, The University of Nottingham\nLouise is a Chartered Psychologist (CPsychol) and HCPC-registered Occupational Psychologist specialising in psychological\, social and organisational issues in occupational health and job retention. She is currently the Course Director for the MSc in Occupational Psychology at the University of Nottingham\, and Lead Academic for the Institute of Mental Health’s Research Support and Consultancy Service. Louise has extensive experience of working in the health and social care sector\, but has also worked with other public and private sector clients\, as well as the third sector. She has been an expert member of three NICE committees developing guidance on: return-to-work after long-term sickness absence; mental well-being at work; and workplace health quality standards. She currently leads the Well-being of the Workforce Study which is exploring the impact of COVID-19 on the mental health and well-being of the UK workforce. \n\nDr Michael Craven\, Senior Research Fellow\, The University of Nottingham\, Institute of Mental Health\nMike is an academic researcher in the NIHR MindTech MedTech Co-operative\, a national centre established in 2013 to focus on developing the evidence and methods needed to bring new technologies for mental health into the National Health Service. He is also a member of University of Nottingham Faculty of Engineering’s Bioengineering research group and the Institute of Mental Health’s Centre for Dementia\, holds an honorary contract with Nottinghamshire Healthcare NHS Foundation Trust and is Health Economist in the Nottingham University Hospitals’ Centre for Healthcare Equipment and Technology Adoption (CHEATA). In MindTech\, Mike contributes expertise in design and evaluation of digital health and medical device related interventions and assistive technologies. He has conducted health technology assessments and reviews for NHS organisations and industry and contributes to policy on digital mental health. Currently\, he is co-investigator on several of MindTech’s large collaborations and trials of technologies which include evaluation of cognitive training software\, remote/mobile mental health and virtual reality therapy\, and various co-design projects with patients and healthcare professionals. \n\nBill Byrom\, Vice President of Product Strategy and Innovation\, Signant Health\nBill leads product strategy and innovation\, and the electronic patient-reported outcomes (ePRO) Science team\, at Signant Health. He has worked in the Pharmaceutical industry for over 25 years and is the author of over 70 publications and two industry textbooks on ePRO. His recent scientific work includes the use of wearable technology and ePRO in clinical trials. Bill is an active member of the Critical Path Institute’s ePRO Consortium\, is a member of the scientific leadership board of the Digital Medicine Society\, and leads a cross-industry working group on wearable technology within the Drug Information Association’s Study Endpoints Community. Bill provides eClinical commentary on LinkedIn and Twitter (@billbyrom).
URL:https://staging.medilinkmidlands.com/event/medical-technologies-systems-special-interest-group-sig-4/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Philip-Breedon-3841-scaled.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200722T110000
DTEND;TZID=Europe/London:20200722T120000
DTSTAMP:20260422T074448
CREATED:20200624T132813Z
LAST-MODIFIED:20200624T132813Z
UID:18233-1595415600-1595419200@staging.medilinkmidlands.com
SUMMARY:WEBINAR: How the NIHR can support your route to market
DESCRIPTION:The National Institute for Health Research (NIHR) Clinical Research Network (CRN) works in partnership with the NHS to deliver high quality research. Join this webinar to gain an understanding of how the NIHR can support your route to market. \nHosted by the NIHR/CRN\, they will cover: \n– The role of the NIHR/CRN \n– What NIHR can currently offer to companies; Clinical Engagement\, Research Funding\, Access to the NHS \n– Plans for future support/priority areas \n– How companies should approach NIHR \n– What can Medilink EM and the Academic Health Science Network do to help \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles:\n\nDaniel Kumar\, Industry Operations Manager\, CRN: East Midlands\nDan has a degree in Business Management Studies and worked for an accountancy firm prior to moving into the NHS in 1996. Currently with over 20 years NHS experience\, as a nurse across Malignant Haematology\, High Dependency and Coronary Care\, Research Nurse\, Manager of a Cancer Research Team and then Senior Manager within Research Governance. Dan led on Industry for Trent CLRN since 2011 prior to this post.\nAs part of the CRNEM leadership team this current role focuses on the development of the commercial research portfolio across all stages of the study lifecycle. This involves a particular focus on recruitment of trials to targets and growth of the sector\, working along with SMEs and Medical Technology. \n\nTheo Christie\, Business Development Manager (Commercial)\, CRN National Coordinating Centre\nTheo facilitates key discussions between the life sciences industry and the Clinical Research Network and is a point of contact for the life sciences companies engaging with the Clinical Research Network. Theo is able to provide advice to companies on how they are able to tap into the Clinical Research Network study support services to ensure clinical studies are set up efficiently and recruit to time and target.\nWith a degree in Clinical Sciences\, Theo has been with the Clinical Research Network since 2013. Before joining the Business Development and Marketing Team\, Theo previously worked within the organisation’s Research Delivery Directorate where he was responsible for supporting interactions between the life sciences industry across 10 therapeutic areas\, providing operational support through feasibility\, set up and patient recruitment. \n\nRoz Sorrie-Rae\, Lead Research Management & Governance Manager\, Leicestershire\, Northamptonshire & Rutland Comprehensive Local Research Network\nRoz has worked in the NHS for over 28 years in the fields of clinical audit and effectiveness\, clinical governance and research. She joined her current role in 2008 and continued in that role when CRN East Midlands was established. From late 2014\, she spent a year in Nova Scotia\, Canada\, and gained an international perspective on health research\, having spent her time abroad working in R&D in the Canadian university sector. On her return to the UK\, she commenced in the role of HRA Approval Business Lead with the National CRN Coordinating Centre. Alongside this national role\, she returned to CRN East Midlands in a senior Research Management & Governance Manager capacity. In November 2016\, she took up the role of CRN East Midlands Study Support Service Operations Manager and has in 2020 moved into a Study Support Service Compliance and Assurance Manager role. During her career\, Roz has co-authored numerous papers and publications\, both as a researcher and subject matter expert\, including a chapter on Budget and Funding in An Introduction to Health Services Research (2014; Sage).
URL:https://staging.medilinkmidlands.com/event/webinar-how-the-nihr-can-support-your-route-to-market/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/dan-kumar-new-1.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200728T110000
DTEND;TZID=Europe/London:20200728T120000
DTSTAMP:20260422T074448
CREATED:20200626T151023Z
LAST-MODIFIED:20200626T151023Z
UID:18262-1595934000-1595937600@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Planning and Conducting an Effective Clinical Trial
DESCRIPTION:Join Afortiori Development Ltd for a practical insight into clinical trials. The webinar will explore: \n• What is a trial?\n• Why do we need a trial?\n• What is a good trial?\n• What exactly is involved in running a trial? \nJoin us to hear about the important considerations and common pitfalls as well as gain a good understanding of the tasks and responsibilities involved for Sponsors. There will be ample opportunity to ask questions and benefit from the wide ranging experience of the presenters. \nThis free to attend meeting will be held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund. Click here to be redirected to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \nNicola Wall \, along with Elizabeth Ralph founded Afortiori Development after long careers in clinical research within a variety of roles. Both bring a commitment to well designed and successfully executed clinical trials. \n \nDr Nicola Wall\, Chief Executive Officer\, Afortiori Development \n \nCharlotte Culver\, Clinical Project Leader\, Afortiori Development
URL:https://staging.medilinkmidlands.com/event/webinar-planning-and-conducting-an-effective-clinical-trial/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Nicola-Wall-scaled.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200729T140000
DTEND;TZID=Europe/London:20200729T150000
DTSTAMP:20260422T074448
CREATED:20200518T115538Z
LAST-MODIFIED:20200518T115538Z
UID:18280-1596031200-1596034800@staging.medilinkmidlands.com
SUMMARY:East Midlands Academic Health Science Network Virtual Coffee Break
DESCRIPTION:A chance to meet other businesses\, share ideas and hear what’s happening from the East Midlands Academic Health Science Network Team. \nJoin EMAHSN for a virtual coffee break on Wednesday 29 July at 2pm. \nNetworking opportunities are a key part of Medilink EM events and whilst the current COVID-19 crisis won’t allow face to face events\, we have introduced this online opportunity to enable the life sciences community to still connect with one another. In this informal gathering\, hosted by Nick Brown\, Commercial Manager at EMAHSN\, you will have the opportunity to share your current challenges and experiences and find out how the EMAHSN can help. \nAt this coffee break we will be joined by Dr Ayokunmi Ajetunmobi\, Venture Development Manager from BioCity Group\, join to find out about the BioCity Accelerator Programmes.  The programme is specifically for life science entrepreneurs\, based upon the Lean- Start Up approach and evidence-based entrepreneurialism.  Not just for start-ups and spin-offs\, the BioCity Business Accelerator Programme works with entrepreneurs at every stage from idea to exit to help businesses to get off the ground\, and continue to grow\, entrepreneurially. \nGrab a coffee\, a biscuit and join us. \nJoining details will provided to delegates by a member of the Medilink EM events team once the online registration form has been completed. \nIf you have any topics that you’d like to discuss in future AHSN coffee breaks\, please feel free to email any suggestions to us by clicking here. \n\nChair and guest details: \n \n  \nNick Brown\, Commercial Manager\, EMAHSN \n  \n  \n  \nDr Ayokunmi Ajetunmobi\, Venture Development Manager\, BioCity Group
URL:https://staging.medilinkmidlands.com/event/east-midlands-academic-health-science-network-virtual-coffee-break-2-2/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/png:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Badge-for-EMAHSN-Events-1.png
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
END:VCALENDAR